<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase-3 (GSK-3) has been linked to the pathogenesis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) </plain></SENT>
<SENT sid="1" pm="."><plain>The debate on the respective contributions of GSK-3α and GSK-3β to AD pathology and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> is ongoing </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, the identification of potent GSK-3α-selective inhibitors, endowed with favorable pharmacokinetic properties, may elucidate the effect of GSK-3α inhibition in AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> models </plain></SENT>
<SENT sid="3" pm="."><plain>The analysis of <z:hpo ids='HP_0000001'>all</z:hpo> available crystallized GSK-3 structures provided a simplified scheme of the relevant hot spots responsible for ligand binding and potency </plain></SENT>
<SENT sid="4" pm="."><plain>This resulted in the identification of novel scorpion shaped GSK-3 inhibitors </plain></SENT>
<SENT sid="5" pm="."><plain>It is noteworthy, compounds 14d and 15b showed the highest GSK-3α selectivity reported so far </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, compound 14d did not display significant inhibition of 48 out of 50 kinases in the test panel </plain></SENT>
<SENT sid="7" pm="."><plain>The GSK-3 inhibitors were further profiled for efficacy and toxicity in the <z:mp ids='MP_0002169'>wild-type</z:mp> (wt) zebrafish embryo assay </plain></SENT>
</text></document>